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Mammalian frataxin directly enhances sulfur
transfer of NFS1 persulﬁde to both ISCU and
free thiols
Aube´rie Parent1, Xavier Elduque2, David Cornu3, Laura Belot1, Jean-Pierre Le Caer1,
Anna Grandas2, Michel B. Toledano4 & Benoit D’Autre´aux1
Friedreich’s ataxia is a severe neurodegenerative disease caused by the decreased expression
of frataxin, a mitochondrial protein that stimulates iron–sulfur (Fe-S) cluster biogenesis. In
mammals, the primary steps of Fe-S cluster assembly are performed by the NFS1–ISD11–ISCU
complex via the formation of a persulﬁde intermediate on NFS1. Here we show that frataxin
modulates the reactvity of NFS1 persulﬁde with thiols. We use maleimide-peptide compounds
along with mass spectrometry to probe cysteine-persulﬁde in NFS1 and ISCU. Our data reveal
that in the presence of ISCU, frataxin enhances the rate of two similar reactions on NFS1
persulﬁde: sulfur transfer to ISCU leading to the accumulation of a persulﬁde on the cysteine
C104 of ISCU, and sulfur transfer to small thiols such as DTT, L-cysteine and GSH leading to
persulfuration of these thiols and ultimately sulﬁde release. These data raise important
questions on the physiological mechanism of Fe-S cluster assembly and point to a unique
function of frataxin as a enhancer of sulfur transfer within the NFS1–ISD11–ISCU complex.
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F
riedreich’s ataxia is a severe neurodegenerative disease
caused by the reduced expression of the small globular
mitochondrial protein, frataxin (FXN)1. In patients and
various models of Friedreich’s ataxia, Fe-S cluster biogenesis and
iron metabolism are impaired2,3. Initial studies on eukaryotic and
prokaryotic FXNs suggested roles in iron storage4, delivery5 and
detoxiﬁcation6, but the physiological relevance of these functions
has been questioned7–10. Recent studies instead point to a direct
role of FXN in Fe-S cluster assembly11–14. Fe-S clusters are
essential prosthetic groups of proteins operating a wide range of
functions from enzymatic catalysis, electron transfer to oxidative
and nitrosative stress sensing15,16. In eukaryotes, Fe-S cluster-
containing proteins are distributed in almost every cellular
compartment, especially in mitochondria, the cytosol and the
nucleus16. The biogenesis of Fe-S clusters is performed by two
main multi-protein machineries, the ISC (Iron–Sulfur Cluster)
machinery localized in mitochondria and the CIA (Cytosolic
Iron–sulfur cluster Assembly) machinery localized in the
cytosol16. The ISC machinery provides Fe-S clusters for
mitochondrial proteins and also synthesizes an unknown
compound that is exported to the cytosol and required for
assembly of Fe-S clusters by the CIA machinery17–19.
The ISC machinery comprises ISCU, a scaffold protein on
which Fe-S clusters are assembled, NFS1, a pyridoxal phosphate-
dependent cysteine desulfurase, ISD11 and FXN20–23. The
eukaryotic ISC machinery has evolved from bacteria and thus
some of the primary steps of Fe-S cluster assembly have been
conserved16,24,25. As a common strategy, nascent Fe-S clusters are
assembled on ISCU from iron and sulﬁde and transferred to
recipient apo-proteins with the assistance of other specialized
proteins. The sulﬁde ions are provided to ISCU in the form of a
persulﬁde intermediate on the catalytic cysteine C383 of NFS1
(NFS1-SSH, where the terminal sulfur is also called sulfane
sulfur) by desulfurization of L-cysteine. ISD11 is proposed to
stabilize NFS1 and also to promote formation of persulﬁde on
NFS1 (refs 12,26,27). In the bacterial system, the sulfane sulfur of
the persulﬁde carried by IscS, the homologue of NFS1, is
transferred to IscU by a trans-persulfuration process leading to
poly-persulfurated IscU28–30. A similar trans-persulfuration
process has been recently decribed with the mammalian
system31. Unfortunately, mechanistic details of the subsequent
steps leading to Fe-S cluster assembly are still lacking.
Mammalian FXN was proposed to stimulate the rate of Fe-S
cluster assembly by enhancing sulﬁde production via binding to
the NFS1–ISD11–ISCU complex11,14,32. This stimulatory effect
was dependent on the presence of ISCU and ultimately favoured
the assembly of [4Fe4S] clusters at the expense of [2Fe2S]
clusters11. In yeast, the homologue of FXN, Yfh1, was proposed to
stimulate the formation of persulﬁde on Nfs1 by increasing the
afﬁnity of L-cysteine for Nfs1 (ref. 12). Intriguingly, and in stark
contrast to the mammalian system, this effect of Yfh1 was
independent of the presence of ISCU. In bacteria, CyaY, the
homologue of eukaryotic FXN, was shown to slow down rather
than stimulate Fe-S assembly on the IscS–IscU complex33 and did
not alter the [2Fe2S]:[4Fe4S] cluster ratio34. These contrasting
data raise important questions concerning the molecular function
of FXN, (both in bacteria and mammals), and the mechanism by
which FXN stimulates sulﬁde production and the rates of Fe-S
cluster assembly.
To determine the mechanism by which mammalian FXN
stimulates Fe-S cluster assembly, we here develop a novel assay to
probe protein persulﬁde that makes use of sulfur-reactive
maleimide-peptide compounds. Along with mass spectrometry
analysis, the maleimide-peptide assays reveal that the sulfane
sulfur of NFS1 is directly and spontaneously transferred to ISCU
leading to the accumulation of a persulﬁde on its cysteine C104.
The single-turnover kinetics of formation, reduction and transfer
of persulﬁde, monitored using the maleimide-peptide assay,
provide evidence that FXN is not required for persulﬁde
formation on NFS1, but enhances the rate of sulfur transfer to
ISCU and cleavage of NFS1 persulﬁde by external thiols such as L-
cysteine and glutathione (GSH), which leads to sulfur transfer on
these thiols and ultimately sulﬁde release. In contrast, FXN does
not impact ISCU persulﬁde reduction. We also show that NFS1
persulﬁde reduction by thiols is the rate-limiting step in multiple-
turnover kinetics and that ISCU persulﬁde is not reduced under
these conditions and thus does not contribute to sulﬁde release.
Thereby, FXN stimulates sulﬁde release exclusively by enhancing
the rate of NFS1 persulﬁde reduction by thiols. However, this
pathway is not efﬁcient for Fe-S cluster assembly on ISCU. These
data shed new light on the molecular function of mammalian
FXN within the ISC machinery and raise questions on the
physiological mechanism of Fe-S cluster assembly.
Results
FXN is not required for NFS1 persulﬁde formation. In mam-
mals, the global rate of sulﬁde production is enhanced by FXN
and decreased by ISCU when thiols are used as reductants11,14,
but a step-by-step characterization of the effects of FXN and
ISCU on the catalytic cycle of NFS1 is still lacking (Fig. 1a). To
monitor the formation and reduction of NFS1 persulﬁde
independently, we developed a new assay enabling the detection
and quantiﬁcation of persulﬁde. This assay is based on the
chemical properties of the persulﬁde group, which contains both
a terminal sulfur amenable to alkylation by maleimide
compounds and a disulﬁde bond that can be cleaved by
reduction (Fig. 1b). In brief, a persulﬁde is revealed by the loss
of the succinimide-peptide moiety (the product of maleimide
reaction with a sulfhydryl) on cleavage of the sulfur–sulfur bond
by dithiothreitol (DTT). To visualize the loss of the succinimide
moiety, we engineered maleimide compounds with a peptide arm
(maleimide-peptide, MalP) of a size sufﬁciently large to be
detected by SDS–polyacrylamide gel electrophoresis (PAGE). The
best results were obtained with a 16-mer MalP (MalP16: 1.95 kDa)
(Fig. 1c). In the absence of L-cysteine (the substrate of NFS1), the
seven cysteines of NFS1 were alkylated by MalP16 (denoted
NFS1þ 7 species) and no loss of the succinimide-peptide moiety
was observed on reduction by DTT, indicating that none of NFS1
cysteines was initially persulfurated (Fig. 1d and Supplementary
Fig. 1a). Following reaction with L-cysteine, the seven cysteines of
NFS1 were still alkylated by MalP16 but reduction by DTT led to
the loss of one succinimide-peptide moiety from the NFS1þ 7
species leading to formation of an NFS1þ 6 species, thereby
indicating the presence of a persulﬁde group on a single cysteine
of NFS1 (Fig. 1d).
In a ﬁrst set of experiments, we monitored the inﬂuences of
ISCU (U) and FXN (F) on the rates of persulﬁde formation
(reaction 1, Fig. 1a) by the NFS1–ISD11 complex (NI). The
NFS1–ISD11 complex (NI), ISCU (U) and FXN (F) have been
shown to form homodimeric ternary and quaternary complexes
with NI:U and NI:U:F stoichiometries of 1:1 and 1:1:1 for each
subunit, respectively11,14,23, which will be denoted NIU and
NIUF thereafter. We conﬁrmed here by size exclusion
chromatography that when incubated together, these proteins
form the NIU and NIUF complex and that FXN does no interact
with the NI complex in the absence of ISCU (Supplementary
Fig. 2a–e). However, by using 100 mM of the NI complex and ﬁve
equivalents of FXN, only a small proportion of FXN was detected
as an NIUF complex, which questioned the efﬁciency of complex
formation at these concentrations. To determine the optimal
protein concentration for NIU and NIUF complexes formation,
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we titrated the amount of FXN and ISCU that would generate the
maximal effect on NFS1 cysteine desulfurase activity
(Supplementary Fig. 2f–h). Maximal attenuation was obtained
with 1M equivalent of ISCU for 20 mM of the NI complex. In the
absence of ISCU, FXN did not alter NFS1 cysteine desulfurase
activity, in agreement with the lack of interaction between FXN
and the NI complex. In the presence of one equivalent of ISCU,
one equivalent of FXN gave the maximal stimulatory effect with
20 mM of the NI complex. At these concentrations, these proteins
are thus predominantly in the form of the NIU and NIUF
complexes. Moreover, these results are consistent with the
reported stoichiometries in the NIU and NIUF complexes11.
We concluded that the low amount of the NIUF complex
detected by size exclusion chromatography at 100 mM was
probably due to dissociation of FXN from the NIU complex
during elution on the gel ﬁltration column. Under these
conditions, NFS1 was almost entirely converted to its
persulfurated form (B95%) 10 s after reaction with L-cysteine,
and this irrespective of the presence of FXN and/or ISCU
(Fig. 2a). Mammalian FXN is thus not required for persulﬁde
formation on NFS1, in contrast to what was shown for the yeast
homologue of FXN, Yfh1, even when using the concentrations of
enzyme and L-cysteine reported in this study (Supplementary
Fig. 1b)12.
We next characterized the persulﬁde formed on NFS1 by mass
spectrometry. The mass spectrum of NFS1 displayed two peaks,
one at 46,322±1Da, identiﬁed as NFS1 (expected mass of
46,322Da) and the other one at 46,500±1Da (Fig. 2b), attributed
to an N-gluconoylated form of NFS1 (þ 178Da) either on the
ﬁrst histidine of the His-tag or on the NH2 N terminus of
NFS1 (ref. 35), as shown by LC-ESI-ORBITRAP-MS/MS
characterization of the peptide mass ﬁngerprint (Supplementary
Fig. 3a,b and Supplementary Table 1). On reaction of the NI
complex with L-cysteine, two major species were detected,
corresponding to NFS1 and its N-gluconoylated form each
carrying a mass increment of 32±1Da, consistent with the
incorporation of a single sulfur atom (Fig. 2c). About 30% of non-
persulfurated NFS1 was also detected that probably originates
from the loss of the sulfane sulfur under the conditions of mass
spectrometry36, as this species was not detected by the alkylation
assay. Similar species were detected when the NI complex was
reacted with L-cysteine in the presence of FXN and/or ISCU
(Supplementary Fig. 3c–e). These results establish that the main
species characterized by the maleimide-peptide assay are mono-
persulfurated forms of NFS1. Importantly, these data conﬁrm the
results of the maleimide-peptide assay indicating that FXN is not
required for persulﬁde formation on NFS1.
FXN enhances sulfur transfer from NFS1 persulﬁde to ISCU.
We next investigated persulﬁde transfer from NFS1 to ISCU
using the maleimide-peptide assay (Fig. 2d). Before reaction of
the NIU complex with L-cysteine and on reaction with MalP16,
the majority of ISCU carried four succinimide-peptide moieties
(denoted ISCUþ 4, see Supplementary Fig. 1c). A small amount
of ISCU (o5%) was mono-persulfurated (ISCUþ 3) as a result of
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Figure 1 | Maleimide-peptide assay principle. (a) Catalytic cycle of the cysteine desulfurase NFS1. (1) formation of persulﬁde on NFS1 (NFS1-SSH) through
PLP-catalyzed desulfurization of L-cysteine that generates L-alanine as a by-product. NFS1 persulﬁde can be reduced by thiols (RSH) by two different
mechanisms: S-thiolation (2) or sulfur transfer (3). The S-thiolation pathway leads ﬁrst to sulﬁde release and S-thiolation of NFS1 (NFS1-SSR) (2a) and then
reduction of NFS1-SSR by a second thiol (2b). The sulfur transfer pathway leads ﬁrst to sulfur transfert on the thiol that generates a persulfurated
thiol (RSSH) (3a) and then hydrogen sulﬁde after reduction by a second thiol (3b) and (2) reduction of NFS1-SSH by a thiol (RSH) that generates a
persulfurated thiol (RSSH) and hydrogen sulﬁde (H2S). (b) Reaction scheme of alkylation assay principle by maleimide-peptide (MalP) for identiﬁcation of
persulﬁde. The reactions of formation and reduction of persulﬁde are quenched by adding MalP (light grey) under denaturing conditions (SDS) that
alkylates all the thiol groups including persulfurated and non-persulfurated cysteines. The presence of a persulfurated cysteine is revealed by the loss of the
succinimide-peptide moiety (dark grey) on reduction of the disulﬁde bond of the persulﬁde by DTT. The different species are then separated by SDS–PAGE.
(c) Structure of the MalP16 maleimide-peptide. (d) Maleimide-peptide assay of NFS1 persulﬁde before and after reaction with L-cysteine. The alkylated
forms of NFS1 are indicated as NFS1þ 7 and NFS1þ6 corresponding to seven and six cysteine residues alkylated by MalP16, respectively.
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persulfuration of the overexpressed protein within bacteria.
Residual amounts of this persulfurated form were still present
after reduction by DTT (see Methods). On reaction of the NIU
complex with L-cysteine, the ISCUþ 4 species was gradually
converted to the ISCUþ 3 species (Fig. 2d,e). Remarkably, when
the reaction was performed in the presence of FXN, the con-
version occurred about 50-fold faster (Table 1). These results
indicate that FXN enhances the rate of persulﬁde formation on
ISCU.
Mass spectrometry analysis showed that after 3min of reaction
of the NIU complex with L-cysteine, ISCU was detected as a main
peak at 14,618±1Da that closely matched the theoretical mass of
reduced ISCU (expected mass 14,618Da) and as a minor peak at
14,649±1Da that corresponds to a mono-persulfurated form of
ISCU (expected mass of 14,650Da) (Fig. 2f and Supplementary
Fig. 3f). When the reaction was performed in the presence of
FXN, ISCU was almost entirely converted into the mono-
persulfurated form with a minor fraction present as a bis-
persulfurated form (expected mass of 14,682Da; Fig. 2g and
Supplementary Fig. 3g). These data conﬁrm that, as observed with
the maleimide-peptide assay, FXN enhances sulfur transfer to
ISCU, and also establish that the species persulfurated on a single
cysteine are mainly mono-persulfurated forms of ISCU.
To establish which of the four cysteine residues of ISCU is(are)
modiﬁed, tryptic digests of the NIU and NIUF complexes were
analysed by LC-ESI-ORBITRAP-MS/MS followed by MS/MS
(Table 2, Supplementary Fig. 4a–d and Supplementary Table 2).
All four ISCU cysteine-containing peptides were detected, and
only those containing C35 and C104 were detected with a
persulﬁde, both in the NIU and NIUF complexes. Semi-
quantitative analysis indicated that C104 was persulfurated by
65% in the NIU complex and by 60% in the NIUF complex,
whereas C35 was persulfurated by 2–5% in either complex
(Table 2). To assess which ISCU cysteine is the primary persulﬁde
receptor, we prepared cysteine-to-serine substitution mutants of
the three conserved ISCU cysteines C35, C61 and C104 (C35S,
C61S and C104S mutants) and used them in the reaction system.
The C61S mutant was only expressed as a truncated polypeptide
that did not inteact with the NI complex and was therefore
discarded (Supplementary Fig. 5). The C35S and C104S ISCU
mutants were expressed as full-length polypeptides that could
form a ternary complex with the NI complex. Using the
maleimide-peptide assay, we observed that the persulfuration of
ISCU was abolished with both the C104S and C35S mutants, and
Table 1 | Effects of FXN and ISCU on the single turnover
kinetic parameters.
Proteins and
complexes
Reductant kNFS1R
(M 1 s 1)
kT (s
 1) kISCUR
(M 1 s 1)
NI DTT 2.9±0.5 NA NA
NIþ F DTT 2.9±0.5 NA NA
NIU DTT 0.6±0.2 0.0017±0.0002 0.23±0.1
NIUF DTT 14±4 40.09* 0.30±0.1
NIUF GSH 0.1±0.05 40.09* E 0
DTT, dithiothreitol; FXN, frataxin; GSH, glutathione; NA, not applicable.
kNFS1R , kT and k
ISCU
R represent the rate constants of NFS1 persulﬁde reduction, NFS1 persulﬁde
transfer to ISCU and ISCU persulﬁde reduction, respectively, determined using maleimide-
peptide assays. Each data set was ﬁtted using second-order and ﬁrst-order rate equations for
reduction and transfer, respectively (see Methods). The values represent the mean of three
independent experiments with associated s.e.
*Indicate the minimum value that can be determined in that case using the maleimide-peptide
assay.
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Figure 2 | Inﬂuence of FXN on NFS1 and ISCU persulﬁde formation. (a) Kinetics of persulﬁde formation on NFS1 in mixtures containing the NI complex
alone (25mM) or the NI complex (25mM) and equimolar amounts of ISCU and/or FXN, monitored by alkylation assay. The reaction was initiated by adding
L-cysteine and analysed under reducing conditions by SDS–PAGE. The þ 7 and þ 6 species represent NFS1 with seven and six cysteines alkylated by
MalP16, respectively. (b,c) ESI-Q/TOF spectra of the NI complex before (b) and after (c) reaction with L-cysteine. The asterisk represents N-gluconoylated
NFS1. (d) Kinetics of ISCU persulﬁde formation in the NIU and NIUF complexes (25 mM) monitored by alkylation assay. The reaction is initiated by L-
cysteine (500mM) and analysed under reducing conditions. The different alkylated forms of ISCU are indicated as ISCUþ4 and ISCUþ 3 corresponding to
four and three cysteines alkylated by MalP16, respectively. (e) Graphical representation of ISCU persulﬁde (ISCU-SSH) formation kinetics in the NIU and
NIUF complexes determined by quantiﬁcation of the gels in c. The percentage of ISCU-SSH is deﬁned by the amount of the þ 3 species relative to the sum
(þ4þ þ 3). The solid line represents the best ﬁt using a ﬁrst-order rate equation. (f,g) ESI-Q/TOF mass spectra of the NIU complex on reaction with L-
cysteine in the absence (f) and presence (g) of FXN. The spectra represent a zoom on 14,000–15,000 range.
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was not inﬂuenced by FXN (Fig. 3). These data indicate that C35
and C104 are both important for trans-persulfuration and/or that
each of these mutations alter the trans-persulfuration process
potentially by modifying the structure of the putative Fe-S
cluster-binding site. Although these data cannot tell which of C35
or C104 is the primary ISCU receptor of NFS1 persulﬁde, they
clearly establish that C104 is the major sink of persulﬁde on
ISCU.
We then enquired how the persulﬁde is transferred from NFS1
to ISCU, whether directly from the PLP cofactor of NFS1, from
NFS1 persulﬁde or via small thiol-containing carriers, speciﬁcally
L-cysteine. Persulfurated NFS1 (NFS1-SSH) was ﬁrst generated,
excess L-cysteine was then removed and ISCU alone or together
with FXN were added. We observed that concomitant to the
disappearance of NFS1 persulﬁde, ISCU became persulfurated.
Moreover, the rate of ISCU persulfuration measured in the
absence of L-cysteine was similar to the one measured in its
presence (Supplementary Fig. 6a,b). These data indicate that the
transfer of sulfur proceeds by a direct attack of one of ISCU
cysteine on NFS1 persulﬁde in both the NIU and NIUF
complexes.
So far we have shown that FXN is not required for persulﬁde
formation on NFS1 but stimulates sulfur transfer from NFS1
persulﬁde to ISCU which could explain the stimulatory effect of
FXN on the global rate of sulﬁde production, if ISCU persulﬁde is
reduced faster than NFS1 persulﬁde and is thus the main source
of sulﬁde. To assess this hypothesis, we sought to determine the
individual rates of persulﬁde reduction for NFS1 and ISCU and to
investigate the inﬂuence of FXN on the rates of these reactions.
FXN enhances sulfur transfer from NFS1 persulﬁde to DTT.
We ﬁrst investigated the reaction of NFS1 persulﬁde reduction
with DTT. The persulﬁdes were generated on NFS1 and ISCU by
incubating mixtures of equimolar amounts of NFS1–ISD11, ISCU
and FXN with L-cysteine. Then, L-cysteine was removed, as it
would regenerate the persulﬁde on NFS1 following its reduction,
and DTT was added. We ﬁrst noticed that NFS1 persulﬁde
reduction was much slower than its formation (Fig. 4a, and see
Fig. 2a), which indicated that reduction of NFS1 persulﬁde is the
rate-limiting step of the cysteine desulfurase cycle under these
conditions (reaction 2 or 3, Fig. 1a). Remarkably, ISCU and FXN
both altered the rate of NFS1 persulﬁde reduction, but in opposite
ways (Fig. 4a,b). While the binding of ISCU to the NI complex
slowed down the reaction, the binding of FXN to the NIU
complex enhanced it, but had no effect on the NI complex. The
data were ﬁtted assuming that reduction of NFS1 persulﬁde by
DTT is a bimolecular reaction (see below, see also Methods;
Table 1). The values of the rate constants indicated that ISCU
slows down the reaction by ﬁvefold and FXN stimulates
the reduction of NFS1 persulﬁde by approximately 25-fold as
compared with NIU
Two different mechanisms of reduction by thiols are feasible,
through S-thiolation of NFS1 or sulfur transfer to the thiol
(Fig. 1a). In the case of the S-thiolation pathway, a DTT adduct is
expected that will appear as an NFS1þ 6 species under non-
reducing conditions in the alkylation assays. Under these
conditions, no NFS1þ 6 species was detected (Supplementary
Fig. 6c), indicating that NFS1 persulﬁde is reduced through sulfur
transfer on DTT. We thus conclude that FXN stimulates and
ISCU slows down sulfur transfer to DTT and that the effect of
FXN relies on the presence of ISCU.
Reduction of ISCU persulﬁde is Q1slower than that of NFS1
persulﬁde and not impacted by FXN. We next examined the
inﬂuence of FXN on the rate of ISCU persulﬁde reduction by
DTT starting from fully persulfurated forms of both NFS1 and
ISCU. The rates of ISCU persulﬁde reduction were similar in the
absence or presence of FXN (Fig. 4c,d), indicating that FXN does
not affect this step. The comparison of the respective rate con-
stants of ISCU and NFS1 persulﬁde reduction by DTT indicated
that reduction of NFS1 persulﬁde is faster than reduction of ISCU
persulﬁde, by threefold in the absence of FXN and 45-fold in its
presence (Table 1), suggesting that ISCU may not contribute to
the global sulﬁde production when DTT is used as a reductant.
Taken together, the results of the single-turnover kinetics
indicate that FXN enhances the rate of two reactions: sulfur
transfer to ISCU and sulfur transfer to DTT. However, since DTT
is not a physiological reductant, we wondered whether the effect
Table 2 | Identiﬁcation of ISCU persulfuratedQ7 peptides in the NIU and NIUF complex.
Peptide Cysteine Expected masses NIU NIUF
CAM S-CAM (O)2-CAM CAM CAMþ 32 % CAM CAMþ 32 %
NVGTGLVGAPACGDVMK C35 1,645.8036 1,677.7757 1,677.7934 1,645.8035 1,677.7759 (31.9724) 5 1,645.8044 1,677.7758 (31.9714) 2
TFGCGSAIASSSLATEWVK C61 1,971.948 2,003.9201 2,003.9378 1,971.9519 ND NA 1,971.9529 ND NA
ELCLPPVK C96 955.5281 987.5002 987.5179 955.5287 ND NA 955.5289 ND NA
LHCSMLAEDAIK C104 1,387.6708 1,419.6429 1,419.6606 1,387.6714 1,419.6429 (31.9715) 65 1,387.6697 1,419.6427 (31.9730) 60
CAM, carbamidomethyl; NA, not applicable; ND, not determined; (O)2-CAM, CAM with two oxygen; S-CAM, CAM with persulﬁde.
LC-ESI-MS/MS-ORBITRAP analysis of the tryptic digests of the NIU and NIU complexes after reaction with L-cysteine. The table displays the expected masses of ISCU cysteine-containing petides
carrying the following modiﬁcations on the cysteine residue: CAM, S-CAM and (O)2-CAM. The experimental masses were determined with a 5-p.p.m. tolerance and those matching the CAM and
CAMþ 32Da modiﬁcations are listed with the corresponding quantiﬁcations (%; see Methods). The mass differences between the CAMþ 32 and CAM peptides are displayed under coma below and are
consistent with a sulfur atom (exact mass 31.9721) but not with two oxygen atoms (exact mass 31.9898).
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Figure 3 | Identiﬁcation of the persulfurated cysteines of ISCU. Alkylation
assays with C35S and C104S ISCU mutants. The kinetics of ISCU persulﬁde
formation in the NIU and NIUF complexes (25mM) prepared with the C35S
and C104S ISCU mutants were initiated with L-cysteine (500mM) and
analysed under reducing conditions. The þ 3 and þ 2 species represent
non-persulfurated and persulfurated ISCU mutants, respectively.
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of FXN and the differences in the rates of persulﬁde reduction
between NFS1 and ISCU could be observed with physiologically
relevant reductants.
L-cysteine and GSH are potential reductantsQ2 of NFS1 persul-
ﬁde. Using the maleimide-peptide assay, we assayed persulﬁde
reductase activities of two electron donors postulated to enable
persulﬁde reduction37–39, ferrous iron (Fe2þ ) and mammalian
mitochondrial ferredoxin 2, FDX2, in its reduced state. Neither
iron alone or together with FDX2 had an impact on NFS1 or
ISCU persulﬁdes (Supplementary Fig. 7a).
We thus tested the thiol-containing molecules, GSH, which
contributes to cytosolic Fe-S cluster assembly in yeast by a still
undeﬁned mechanism40,41 and L-cysteine. GSH did not affect
ISCU persulﬁde even after 60min, but could reduce NFS1
persulﬁde (Supplementary Fig. 7b) albeit at a rate approximately
140-times lower than DTT (Table 1). To test L-cysteine, the
maleimide-peptide assay could not be used since L-cysteine would
regenerate NFS1 persulﬁde following its reduction. We instead
monitored L-alanine production (Fig. 5a). For each concentration
of L-cysteine, the amount of L-alanine generated exceeded the
concentration of the NI complex, which indicated that several
turnovers were achieved and thus that L-cysteine was able to
reduce NFS1 persulﬁde. Cystine (oxidized cysteine), which is the
expected by-product of persulﬁde reduction by L-cysteine, was
concomitantly generated in the reaction mixture, further
supporting this conclusion (Supplementary Fig. 7c–e). To
determine whether L-cysteine reduces NFS1 through sulfur
transfer or S-thiolation (Fig. 1a), we analysed the kinetics of
persulﬁde formation under non-reducing conditions since an
NFS1þ 6 species is expected to appear in the case of the
S-thiolation pathway. No L-cysteine adduct was detected under
these conditions, which is consistent with the sulfur transfer
mechanism of reduction (Fig. 1d and Supplementary Fig. 1b).
Moreover, the kinetics of Fe-S cluster reconstitution performed
with L-cysteine as a reductant (without DTT), displayed a lag
phase indicative of a delay in sulﬁde release (Supplementary
Fig. 8a–c). Such a lag phase is not expected in the case of the S-
thiolation mechanism for which sulﬁde release should initiates
immediately on adding L-cysteine, whereas it is consistent with
the sulfur transfer mechanism for which sulﬁde release is not
directly correlated with NFS1 persulﬁde reduction but with the
subsequent step of reduction of the persulfurated thiol (Fig. 1a,
reaction (3b)). These data thus further support the sulfur transfer
mechanism.
Altogether, the single-turnover kinetics indicate that thiols
such as DTT, L-cysteine and GSH are able to reduce NFS1 and
ISCU persulﬁdes but these reactions are not synchronized. The
reduction of NFS1 persulﬁde by thiols is apparently more efﬁcient
than the reduction of ISCU persulﬁde. We have thus asked
whether the reduction of ISCU contributes to sulﬁde release in
multiple-turnover kinetics.
FXN enhances NFS1 persulﬁde reduction by Q3L-cysteine in
multiple turnovers. We investigated the inﬂuence of FXN on the
rate of L-alanine production. Analysis of multiple-turnover
kinetics under steady-state conditions is also a powerful tool to
determine the mechanism by which L-cysteine reduces protein
persulﬁde. Two mechanisms were considered: (i) formation of an
enzyme–substrate complex as described by the Michaelis–Menten
model for which the initial velocity reaches a plateau when the
concentration of substrate increases as the enzyme becomes
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Figure 4 | Inﬂuence of FXN on the reduction of NFS1 and ISCU persulﬁdes. (a) Kinetics of NFS1 persulﬁde reduction in mixtures containing the NI
complex alone (25mM) or the NI complex (25mM) and equimolar amounts of ISCU and/or FXN, monitored by alkylation assay. The reaction was initiated
by DTT (1mM) and analysed under reducing conditions. The reduction of NFS1 persulﬁde was characterized by appearance of the NFS1þ 7 species.
The ‘v’ symbol indicates the time to reach 50% reduced NFS1. (b) Graphical representation of NFS1 persulﬁde reduction kinetics determined from
quantiﬁcation of the gels in a. The percentage of NFS1-SSH is deﬁned by the amount of the þ 6 species relative to the sum (þ 7þ þ6). The solid line
represents the best ﬁt using a second-order rate equation. (c) Kinetics of ISCU persulﬁde reduction in the NIU and NIUF complexes (25mM) monitored by
alkylation assay. The reaction is initiated with DTT (1mM) and analysed under reducing conditions. The reduction of ISCU-SSH is characterized by
the appearance of the þ4 species corresponding to non-persulfurated ISCU. (d) Graphical representation of ISCU persulﬁde (ISCU-SSH) reduction
kinetics in the NIU and NIUF complexes, determined by quantiﬁcation of the gels in c. The solid line represents the best ﬁt using a second-order rate
equation.
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saturated42 and (ii) a bimolecular process for which non-
saturation behaviour is expected. We thus measured initial
velocities of L-alanine production under steady-state conditions
(see Methods) for various concentrations of L-cysteine. The
variations of the initial velocities of L-alanine formation by the NI
complex alone or in the presence of equimolar amounts of FXN
and/or ISCU displayed a linear relationship with the
concentration of L-cysteine up to 2mM (Fig. 5b,c). Such
behaviour is a feature of bimolecular reactions. A similar
mechanism was reported for the IscS-like cysteine desulfurase
Slr0387 from Synechocystis sp. PCC 6803 that exhibited second-
order kinetic with thiols as reducers of the persulﬁde43. However,
saturation behaviours that were interpreted using the Michaelis–
Menten model, were obtained by other groups with mammalian
NFS1 using higher L-cysteine to NFS1 ratios (1,000 equivalents of
L-cysteine for the highest concentration versus 100 equivalents of
L-cysteine here)11,14,32. By increasing L-cysteine concentration
above 2mM, we indeed observed that the variation of the initial
velocity deviated from linearity and even decreased at very high L-
cysteine concentrations for the NIU complex (Supplementary
Fig. 9a). Analysis using the Michaelis–Menten equation yielded
KM values in the range of 50–150mM. These KM values are
unlikely physiological. Moreover, they are much higher than
those reported earlier, that is, in the 10–40 mM range11,14,32,
indicating that the KM values are concentration dependent, which
is not consistent with an enzyme–substrate model. L-cysteine and
DTT were reported to inhibit the cysteine desulfurase Slr0387
from Synechocystis sp. PCC 6803 and NifS from E. coli43,44.
Therefore, we hypothesized that the saturation behaviours
observed by other groups with NFS1 could be due to inhibition
caused by L-cysteine itself at ratios above 100 equivalents.
The bimolecular rate constants determined by linear regression
of the data indicated that FXN did not alter the rate of L-alanine
production by the NI complex but signiﬁcantly enhanced it in the
presence of ISCU (Fig. 5b,c and Table 3). Conversely, the binding
of ISCU to the NI complex decreased the rate of L-alanine
production by the NI complex. These effects are reminiscent of
the effects of FXN and ISCU on NFS1 persulﬁde reduction by
DTT observed by single-turnover kinetics (see Fig. 4a,b).
However, in these multiple-turnover kinetics, the reduction of
ISCU persulﬁde may also contribute to the global rate of L-alanine
production, we thus sought to determine the rate-limiting step of
the catalytic cycle.
To selectively disturb persulﬁde reduction without affecting its
formation, we examined the inﬂuence of DTT on the global rate
of L-alanine production, since DTT is only involved in the
reduction step. We observed that the initial velocity of L-alanine
production increased with the concentration of DTT, which is a
ﬁrst indication that reduction is rate-limiting (Supplementary
Fig. 9b). This conclusion was supported by a second observation.
The plot of L-alanine formation by the NI complex alone or in the
presence of FXN and/or ISCU, when extrapolated to t¼ 0 did not
intersect the y axis at y¼ 0 and the amount of L-alanine generated
was correlated to the amount of complex (Supplementary
Fig. 9c–g). This initial burst represents the amount of L-alanine
generated during the ﬁrst half-turnover of NFS1 persulﬁde
formation (reaction 1, Fig. 1a) and the following part of the
reaction (t40) reﬂects subsequent turnovers for which reduction
is now required. The respective rates of these two different
phases:420 mMs 1 for persulﬁde formation and in the range of
0.1 to 1 mMs 1 for the second part indicate that reduction is
slowing down the reaction and thus that it is the rate-limiting
step. A similar initial burst was observed in the absence of DTT
with L-cysteine as the reductant, indicating that reduction is still
rate limiting under this condition (Supplementary Fig. 9h).
The single-turnover kinetics indicated that the reduction of
ISCU persulﬁde by thiols is slower than the reduction of NFS1
persulﬁde and we conﬁrmed that ISCU persulﬁde does not
contribute to the global rate of L-alanine production by measuring
the rates of L-alanine production by the NIU complexes
assembled from the C104S and C104G ISCU mutants that are
non-persulfurable (Supplementary Fig. 9i). Moreover, the bimo-
lecular rate constants for reduction by DTT determined from the
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Figure 5 | Effects of FXN on the NFS1–ISD11–ISCU complex in multiple-turnover kinetics. (a) Effects of L-cysteine concentration on the amount of L-
alanine produced by the NIUF complex. The reactions were performed with the NIUF complex (20 mM) and increasing amounts of L-cysteine in the absence
of DTT. L-alanine production was monitored by ADH assays after 10min of reaction. (b,c) Effect of FXN and ISCU on the initial velocities of L-alanine
formation under steady-state conditions. The NI complex (20mM) alone and with equimolar amounts of FXN (b) and the NIU and NIUF complexes
(20mM) (c) were incubated with various amounts of L-cysteine and the initial velocities were plotted as a function of L-cysteine concentrations. The bars
represent the s.e. from three independent experiments. The lines represent the linear regression.
Table 3 | Effects of FXN and ISCU on the multiple turnover
kinetic parameters.
Proteins and complexes Reductant kNFS1R;MT (M
 1 s 1)
NI L-cys 6.1±0.5
NIþ F L-cys 6.2±0.5
NIU L-cys 1.2±0.2
NIUF L-cys 7.1±0.5
NI DTT 5.3±0.5
NIþ F DTT 5.0±0.5
NIU DTT 0.6±0.2
NIUF DTT 12±1
DTT, dithiothreitol; FXN, frataxin; L-cys, L-cysteine.
The bimolecular rate constants of NFS1 persulﬁde reduction, kNFS1R;MT, were determined from
multiple-turnover kinetics by linear regression of the initial velocities of L-alanine formation
plotted as a function of initial reductant concentrations.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6686 ARTICLE
NATURE COMMUNICATIONS | 5:5686 | DOI: 10.1038/ncomms6686 | www.nature.com/naturecommunications 7
& 2014 Macmillan Publishers Limited. All rights reserved.
multiple turnover experiments were in very good agreement with
those determined in single turnover for reduction of NFS1
persulﬁde by DTT (compare Tables 1 and 3 for DTT). We thus
identify persulﬁde reduction as the rate-limiting step of the
catalytic cycle, while ISCU persulﬁde reduction does not
contribute. These results establish that FXN stimulates and ISCU
slows down the reduction of NFS1 persulﬁde by thiols.
Discussion
The functional role of the small mitochondrial protein FXN has
been the focus of much interest since its discovery8. Only recently
it was demonstrated that FXN associates with the early
components of the mitochondrial Fe-S cluster biogenesis
pathway, NFS1 and ISCU2,23. It was then reported that in the
presence of ISCU, mammalian FXN stimulates sulﬁde production
by NFS1 and this was correlated with stimulation of Fe-S cluster
assembly11,14. Here we conﬁrm that FXN interacts with the
ternary NFS1–ISD11–ISCU (NIU) complex to form a quaternary
NFS1–ISD11–ISCU–FXN (NIUF) complex. Our titration assays
indicate that FXN is mainly associated with the NIU complex at
20 mM and similar results were obtained by other groups with
protein concentrations down to 1 mM11,14, which means that the
dissociation constant of the NIUF complex is much lower than
1 mM. However, the size exclusion chromatography proﬁles show
that FXN dissociates from the NIU complex during elution at
100mM, whereas ISCU remained associated with NFS1 in the
same conditions. These observations suggest that the inteaction of
FXN with the NIU complex may be more dynamic than the
interaction of ISCU with NFS1 (rapid versus slow dissociation) as
also proposed in another study45 and possibly to facilitate
exchange with other accessory proteins on the NIU complex.
We have then studied the mechanism by which FXN may
stimulates Fe-S cluster assembly. Here we show that FXN
modulates the rate of sulfur transfer to ISCU and reduction of
NFS1 persulﬁde by free thiols. To reach this conclusion, we have
developed a novel method to probe and quantify protein
persulﬁdes. This assay is based on detection of protein gel
mobility shifts on reduction of persulfurated cysteine labelled
with synthetic maleimide-peptide and was validated by direct
identiﬁcation of persulﬁde through mass spectrometry analysis.
Compared with the other techniques described for identiﬁcation
of persulﬁde46–48, the peptide-maleimide assay provides
additional advantages, including the small number of steps
required before analysis, its selectivity and owing to its
ratiometric nature it provides an accurate quantiﬁcation of the
ratio of persulfurated versus non-persulfurated species. Moreover,
it is the ﬁrst assay enabling determination of the number of
persulfurated cysteines residues.
This assay was a powerful tool to disentangle formation,
reduction and transfer of NFS1 persulﬁde and thereby to study
single-turnover kinetics of these reactions. We have characterized
the different events triggered by the reaction of NFS1 with L-
cysteine and we have estimated the rates of the these reactions.
The reaction is initiated by the formation of a persulﬁde on NFS1,
which is the fastest reaction of the catalytic cycle. The sulfane
sulfur of NFS1 persulﬁde is then rapidly transferred to ISCU in a
trans-persulfuration process leading to persulfuration of ISCU on
one of its cysteine residues. On regeneration of NFS1 persulﬁde
by L-cysteine, this persulﬁde is reduced by external thiols such as
DTT, GSH and L-cysteine. The reduction of NFS1 persulﬁde
likely proceeds by sulfur transfer rather than S-thiolation
(Fig. 1a). ISCU persulﬁde is also reduced by external thiols but
at a markedly slower rate than NFS1 persulﬁde. The analysis by
mass spectrometry indicates that the persulﬁdes generated on
NFS1 and ISCU are mainly mono-persulﬁdes. Although we
cannot ﬁrmly establish which of the three conserved cysteine of
ISCU (C35, C61 or C104) is the primary receptor of NFS1
persulﬁde, we have identiﬁed C104 as the main persulfurated
cysteine of ISCU. We have also demonstrated that this reaction is
direct and proceeds by a direct nucleophilic attack of one ISCU
cysteine on the persulﬁde of NFS1.
We have then investigated the inﬂuence of FXN on these
reactions. The single-turnover kinetics ﬁrst provide evidence that
formation of NFS1 persulﬁde reaches E95% completion in 10 s,
irrespective of the presence of ISCU and/or FXN. We thus
conclude that FXN is not required for persulﬁde formation of
NFS1 as conﬁrmed by mass spectrometry analysis. These results
challenge two recent studies reporting a stimulatory effect of FXN
and its yeast homologue, Yfh1, on NFS1 persulﬁde forma-
tion12,31. In these studies, the formation of persulﬁde was
monitored using 35S labelling of L-cysteine. Unfortunately, as
the persulﬁde were not protected by alkylation before running
electrophoresis under denaturating conditions, it is not excluded
that they were reduced or exchanged with other cysteines, which
may explain the discrepancy between our respective studies.
However, since the formation of NFS1 persulﬁde was almost
complete in 10 s for all the complexes, we cannot exclude the
possibility that FXN stimulates persulﬁde formation on a
timescale below 10 s.
The single-turnover kinetics reveal that FXN enhances the rate
of sulfur transfer from NFS1 persulﬁde to ISCU and sulfur
transfer of NFS1 persulﬁde to the small thiol-containing molecule
DTT, L-cysteine and GSH. Conversely, ISCU slows down sulfur
transfer to these thiols. In contrast, FXN does not alter the rate of
ISCU persulﬁde reduction. The multiple-turnover kinetics
indicate that the reduction of NFS1 persulﬁde is the rate-limting
step of the catalytic cycle, hence that the effects of FXN and ISCU
on the global rate of the reaction are only related to a modulation
of the rate of NFS1 persulﬁde transfer to these thiols, regardless of
a possible additional effect of FXN on NFS1 persulﬁde formation.
These data conﬁrm the results of the single-turnover kinetics. The
reduction step is also the rate-limiting reaction of the catalytic
cycle of other group I cysteine desulfurases, which suggests that
this might be a common feature of this class of enzymes43,44,49.
Taken together, our results thus point to a unique molecular
function of FXN as an enhancer of sulfur transfer to ISCU and
small free thiols (Fig. 6). Sulﬁde release does occur subsequently,
on condensation of the persulfurated thiol with a second thiol
(Fig. 1a, reaction (3b)), but is not directly catalysed by FXN.
These results rule out the hypothesis that FXN stimulates
sulﬁde release by enhancing persulﬁde formation on NFS1, as
proposed by others11,12,14,31. FXN has also been proposed to
stimulate iron entry within the NIU complex in Fe-S cluster
reconstitution assays with DTT11. However, since the stimulation
of sulﬁde release, in turn increases the amount of iron bound in
the form of Fe-S clusters, the higher proportion of iron bound to
the NIUF complex versus the NIU complex, might be a
consequence of the enhancement of sulﬁde production by FXN.
These data raise several questions on the physiological
mechanism of Fe-S cluster biogenesis: what is the respective role
of the two reactions of transfer? Are these reactions correlated
with physiologically relevant Fe-S cluster assembly on ISCU? We
ﬁrst determined that ISCU persulﬁde does not contribute to
sulﬁde Q4release and is not even reduced in Fe-S cluster
reconstitution assays when thiols are used as reductants
(Supplementary Fig. 10a–d). Thus, under these conditions, sulﬁde
production arises exclusively from reduction of NFS1 persulﬁde
and FXN drives Fe-S cluster assembly by enhancing this reaction.
However, the rate of Fe-S cluster assembly is slow when DTT
and/or L-cysteine are used as reductants (1 h to complete
reconstitution on ISCU with L-cysteine) and the reconstitution
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is inefﬁcient as at least 30 equivalents of sulﬁde ions are produced
in 1 h with L-cysteine (according to the rate constants, Table 3)
while only two equivalents would be required for building up a
[2Fe2S] cluster (Supplementary Figs 8 and 10). These observa-
tions suggest that L-cysteine (and also GSH which is an even less
efﬁcient reducer of NFS1 persulﬁde) are not the physiological
reductants or that other accessory proteins might be required to
secure Fe-S cluster assembly. More likely, since FXN speciﬁcally
activates sulfur transfer to ISCU, the persulfuration of ISCU
might have a functional role in Fe-S cluster assembly but a
dedicated reductase is lacking in theFe-S cluster reconstitution
assays. The human ferredoxin FDX2, which provides electrons for
Fe-S cluster biogenesis38,39, is a potentiel candidate for the
reduction of ISCU. However, under our conditions, we were not
able to measure any persulﬁde reductase activity with FDX2.
Nervertheless, we cannot exclude that under physiological
conditions, FDX2 could be involved in the reduction of ISCU
and NFS1 persulﬁdes by a mechanism that still needs to be
deﬁned. Following this hypothesis, the stimulation of sulfur
transfer to small thiol molecules by FXN may serve another
function, possibly sulfur trafﬁcking within the cell.
Collectively, our data point to a speciﬁc role of FXN in the
control of NFS1 persulﬁde reduction by thiols, enhancing sulfur
transfer to both ISCU and free thiols such as L-cysteine and GSH.
These data shed new light on the molecular function of FXN and
on the early steps of Fe-S cluster assembly by raising important
physiological questions on the mechanism of Fe-S cluster
biogenesis.
Methods
Chemicals and biochemical products. Luria Bertani medium, protease inhibitor
cocktail, N,N’-diisopropylcarbodiimide, DTT, dithionite, trichloroacetic acid
(TCA), L-cysteine, L-alanine, L-cystine, L-alanine dehydrogenase (ADH), b-nicoti-
namide adenine dinucleotide hydrate (NADþ ), ferrous ammonium sulfate
(Fe(NH4)2(SO4)2), His6-thrombin, iodoacetamide (IAA) were from Sigma-Aldrich;
isopropyl-b-D-1-thiogalactopyranoside was from AppliChem; disuccinimidyl tar-
trate from Pierce; trypsin (sequence grade) from Promega; Fmoc-amino acids and
the Rink amide p-methylbenzlhydrylamine support were from Novabiochem; 3-
maleimidopropanoic acid was from Bachem; 1-hydroxybenzotriazole
(HOBt H2O) from Acros Organics and ACCQ-ﬂuo reagent kit from Waters.
HiTrap chelating HP column (5ml), HiPrep Desalting 26/10, HiLoad 26/600 prep
grade Superdex 200 and Superdex 75 columns were from GE Healthcare; Amicon
Ultra centrifugal ﬁlter ultracel 10 and 30 kDa from MILLIPORE, MicroBio-Spin6
columns from Bio-Rad; Rosetta2-(DE3) and pET28b from Novagen.
Plasmid and cell culture puriﬁcation. The vectors expressing NFS1-(amino acid
(aa) 59 to 459), ISD11, ISCU-(aa 36–168) and FXN-(aa 79–207) were kindly
provided by Dr He´le`ne Puccio (IGBMC, Strasbourg) and their construction was
reported earlier11. His-tags followed by thrombin (Thr) cleavage sites were
introduced by mutagenesis leading to the expression plasmids pCDFDuet-
(site1):His6-Thr-NFS1-(site2):ISD11, pETDuet-(site1):His6-Thr-ISCU and pET16-
His6-Thr-FXN. The C35S, C61S, C104S and C104G mutations were introduced in
ISCU by site-directed mutagenesis (IMAGIF platform, Gif Sur Yvette, France). The
vectors expressing human His6-Thr-FDX2 (aa 53–183) from pET28b was
generated by GenScript (Piscataway, USA). The Rosetta2-(DE3) cells were
transformed with the plasmids and the cells were grown from a single colony at
180 r.p.m. at 37 C in Luria Bertani medium with appropriate antibiotics. Protein
expression was induced when the cells reached OD600¼ 0.6 using 500 mM
isopropyl-b-D-1-thiogalactopyranoside and the cells incubated for an additional
16 h at 18 C at 180 rpm. The cell cultures were harvested by centrifugation at
5,500 r.p.m. for 10min at 4 C. Cell pellets were resuspended in buffer A (50mM
Na2HPO4, 150mM NaCl, 5mM imidazole, pH 8) containing a protease inhibitor
cocktail. The cell suspensions were lysed by three cycles of French Press. Cell debris
were removed by centrifugation at 45,000 r.p.m. for 45min at 4 C. The His-tagged
proteins NFS1–ISD11, ISCU (WT and mutants), FXN and FDX2 were puriﬁed on
a HiTrap chelating HP loaded with nickel ions. The resin was washed with buffer A
and bound proteins were eluted by a linear gradient between buffer A and buffer B
(50mM Na2HPO4, 150mM NaCl, 500mM imidazole, pH 8). Protein fractions
were mixed and concentrated on Amicon 10 or 30 kDa to 4ml. The partially
puriﬁed His6-NFS1–ISD11 complex was incubated for 10min with 10mM DTT at
room temperature to remove persulﬁde and then loaded on a HiLoad 26/600
Superdex 200 prep grade column pre-equilibrated with buffer C (50mM Na2HPO4,
150mM NaCl, pH 8). The His-tag could not be removed from the NFS1–ISD11
complex as cleavage by thrombin yields non-speciﬁc cleavages. The ISCU (WT and
mutants), FXN and FDX2 proteins were buffer exchanged on HiPrep Desalting 26/
10 and the His-tags were successfully removed by treatment with thrombin (3.5
NIH unit of His6-thrombin per mg of proteins) for 16 h at 22 C. Before thrombin
cleavage, ISCU and FXN both migrate as a double band on SDS–PAGE, indicating
that signiﬁcant amounts of these proteins were partially modiﬁed. We have
attributed this modiﬁcation to an N-gluconoylation of the His-tag as described for
NFS1 (Fig. 2b,c, Supplementary Fig. 3a,b and Supplementary Table 1), since FXN
and ISCU are no longer modiﬁed after cleavage of the His-tag according to mass
spectrometry (Fig. 2f,g). The His-tag fragments and His6-thrombin were removed
by puriﬁcation on a HiTrap chelating HP loaded with nickel ions and equilibrated
with buffer A. The ISCU proteins (WT and mutants) were incubated with 10mM
DTT for 10min to remove persulﬁde. The ISCU (WT and mutants) and FDX2
proteins were loaded on a HiLoad 26/600 Superdex 75 prep grade column pre-
equilibrated with buffer C. All the proteins were aliquoted and stored in glycerol
(10% ﬁnal) at  80 C. Protein concentrations were determined from absorbance
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Figure 6 | Molecular model for the function of FXN in the ISC machinery. In the presence of FXN, the rates of two reactions are enhanced (a) sulfur
transfer to ISCU and (b) sulfur transfer to free thiol-containing molecules (RSH) such as L-cysteine and GSH. The rate constants are indicated. For
comparison of the rates of transfer to ISCU and RSH, a ﬁrst-order rate constant for sulfur transfer to RSH has been computed assuming a concentration of
100mM of L-cysteine that is close to the physiological concentration50.
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at 280 nm. The puriﬁed C61S ISCU mutant migrated on SDS–PAGE with an
apparent molecular weight of 10 kDa suggesting that the protein is truncated.
Formation of complexes by size exclusion chromatography. The formation of
complexes was analysed by size exclusion chromatography using a Superdex S200
10/300 column (GE Healthcare). The proteins were mix together in buffer C and
eluted at a ﬂow rate of 0.8mlmin 1 and 0.5ml fractions were collected for SDS–
PAGE analysis. The column was calibrated using a calibration kit (Sigma). For the
detection of the NIU complexes, 250 ml of a mixture containing 20 mM of the NI
complex with equimolar amounts of ISCU (WT and cysteine mutants) was
injected; for detection of the NIUF complexes, 200 ml of a mixture containing
100mM of the NI complex with three equivalents of ISCU and ﬁve equivalents of
the His-tagged version of FXN was injected.
Synthesis of MalP16. The maleimide-peptide compound MalP16 comprises a
maleimide moity linked to the 16-mer Leu-Val-Pro-Arg-Gly-Ser-Tyr-Lys-Gly-Thr-
Ser-Lys-Leu-Asn-Tyr-Leu-NH2 peptide. The peptide was elongated manually in a
polyethylene syringe ﬁtted with a polypropylene disc. Washing (3 ) of the Rink
amide resin with dichloromethane (DCM) and N,N-dimethylformamide was
followed by treatment with 20% piperidine/DMF (215min) and washing (DCM,
DMF, MeOH). Coupling conditions: 3M equivalents (eq.) of Fmoc-amino acid,
1-hydroxybenzotriazole and N,N 0-diisopropylcarbodiimide (minimum amount of
DCM and a few drops of DMF, 90min), followed by washing (DCM, DMF and
MeOH). Incomplete couplings (Kaiser test) were repeated with 2 eq. of reagents.
Removal of Fmoc groups: 20% piperidine/DMF (13minþ 110min), followed by
washing (DMF, DCM). Activation of 3-maleimidopropanoic acid was carried out
with the carbodiimide.
Final deprotection conditions: 90:5:5 TFA:H2O:triisopropylsilane (21 h).
Collected ﬁltrate and DCM washings were concentrated under an N2 stream and
cold diethyl ether (10 volumes) was added to the resulting oil. The mixture was
centrifuged (10min, 5 C, 4,800 r.p.m.) and decanted. This procedure was repeated
three times. High-performance liquid chromatography (HPLC) puriﬁcation:
Phenomenex semipreparative Jupiter Proteo column (10m, 90Å, 25,010.0mm), A:
0.1% TFA in water, B: 0.1% TFA in acetonitrile, 3mlmin 1, 280 nm, linear
gradient from 25 to 50% of B. Fractions containing the pure peptide were pooled
and lyophilized. Overall yield (from ultraviolet quantiﬁcation, Tyr:
280¼ 1,480M 1 cm 1): 22%. Analytical HPLC: Jupiter Proteo column (4m, 90Å,
2,504.6mm), A: 0.045% TFA in water, B: 0.036% TFA in acetonitrile, 1mlmin 1,
280 nm, linear gradient from 20 to 40% of B in 30min, tR¼ 13.3min. Matrix-
assisted laser desorption/ionization-time-of-ﬂight mass spectrometry (reﬂector,
2,5-dihydroxybenzoic acidþ 0.1% TFA, positive mode): m/z 1,946.4 [MþH]þ ,
1,968.4 [MþNa]þ , 1,984.4 [MþK]þ ; M calc. for C89H140N24O25 1,945.0.
Maleimide-peptide alkylation assay. The MalP16 was dissolved in puriﬁed water.
All maleimide-peptide alkylation assays, unless indicated, were performed in buffer
C using 25mM NFS1–ISD11 and equimolar amounts of ISCU (WT and mutants)
and/or FXN. For studies of persulﬁde formation, the reactions were initiated with
L-cysteine (500 mM) and incubated at 25 C. For studies of persulﬁde reduction,
fully persulfurated NFS1 and ISCU were generated by incubating the NI complex
in the presence of equimolar amount of FXN or FXN and ISCU (NIUF complex)
for 3min and the NIU complex for 25min at 25 C with 500 mM L-cysteine to reach
completion of the trans-persulfuration reaction. Excess L-cysteine was removed by
desalting on micro-BioSpin6. Next the reduction reactions were initiated by adding
the reductant and the complexes were incubated at 25 C. Most experiments were
performed with DTT (1mM) as a reductant. Other reductants were also tested:
GSH (1mM), reduced FDX2 and Fe2þ (see Supplementary Fig. 7). Reaction
kinetics (formation and reduction) were monitored by sampling 10 ml of the
reaction mixture at different time points, as indicated in the ﬁgures, and the
reaction was stopped using either a 1.5-fold molar excess of MalP16 relative to free
thiols (protein cysteines, L-cysteine and possibly DTT) and SDS (2%) or TCA to a
ﬁnal concentration of 10%. For the TCA precipitation procedure, the reaction
mixture was mixed with an equal volume of ice-cold TCA (20%) and the pellets
were washed three times with ice-cold acetone. The protein pellets were resus-
pended in 10ml buffer C containing 8 M urea and 10mM MalP16. The reactions
quenched by MalP16/SDS and TCA were incubated for 20 min at 30 C, with
constant shaking at 550 r.p.m. Half-reaction volumes were incubated with 1 ml of
DTT at 100mM for 20min at 25 C. Each reaction aliquot (7–8 ml) was analysed
(500 ng of proteins) on 8 and 14% SDS–PAGE gels in non-reducing (without DTT)
and reducing conditions (with DTT). TCA precipitation yielded essentially the
same results as the MalP16/SDS quenching procedure, thus MalP16/SDS quenching
was used on a day-to-day basis.
Controls were used to determine the total number of cysteines available for
alkylation by MalP16 in NFS1, which contains seven cysteine residues, and ISCU,
which contains four cysteine residues (Supplementary Fig. 1a,c). MalP16 (2 eq.)
relative to total sulfhydryl content were added to NFS1 (20 mM) or to a mixture of
NFS1 (20 mM) and ISCU (20 mM) in buffer C, and the alkylation reaction was
stopped after 30 s using the TCA procedure. Several other modiﬁcations engaging
one or two cysteines could give rise to a false positive (non-alkylable cysteine
residue), such as sulfenic, sulﬁnic or sulfonic acid, sulfenamide and disulﬁde bond,
but this can be readily circumvented by analysing the proteins under non-reducing
conditions where non-alkylable cysteines can be detected.
Finally, the protein bands on SDS–PAGE were quantiﬁed using an Odyssey
scanner (Li-Cor). The uncropped images of the gels used for the various ﬁgures are
displayed in Supplementary Figs 11 and 12. The data obtained for persulﬁde
reduction by DTT and GSH were ﬁtted assuming a bimolecular mechanism as
demonstrated in multiple-turnover kinetics for NFS1 persulﬁde reduction (see
Fig. 5c,d) using equation (1) for second-order kinetic42,
v¼E0 expð kRS0tÞð Þ ð1Þ
where S0 is the initial concentration of reductant (DTT or GSH) and kR the
bimolecular rate constant. The data of transfer were ﬁtted assuming a
monomolecular mechanism using equation (2) for ﬁrst-order kinetic42.
v¼E0 1 expð kTtÞð Þ ð2Þ
For studies as performed by Pandey et al.12, maleimide Q5-peptide alkylation assays
were performed in a ﬁnal volume of 200 ml in buffer C using 50 nM of the NFS1–
ISD11 complex with or without an equimolar amount of FXN. The reactions were
initiated with 2 eq. of L-cysteine (100 nM) and were incubated for 15min at 30 C.
The reactions were stopped using 50 eq. of MalP16 relative to free thiols (cysteine
from proteins and L-cysteine) and 2% SDS. The reaction mixtures were incubated
for 20min at 30 C. Half-reaction volumes were incubated with 1 ml of 100mM
DTT for 20min at 25 C. The samples (85 ml) were concentrated using a SpeedVac
apparatus to 20–25 ml. The samples were analysed on 8% SDS–PAGE gels in non-
reducing (without DTT) and reducing conditions (with DTT).
Cysteine desulfurase assays. The amount of L-alanine generated during the
reaction was determined using L-ADH, which generates 1M equivalent of NADH
per L-alanine consumed (denoted ADH assay in the text). The reactions were
performed in buffer C and initiated using L-cysteine at various concentrations as
indicated in the ﬁgure legends and incubated at 25 C. Samples (10, 20 or 30 ml)
were withdrawn from the solution at various time points and the reaction was
stopped using TCA precipitation (0.8% ﬁnal). After 5min of incubation on ice, the
samples were centrifuged at 14,500 r.p.m. for 4min at room temperature and
NaOH at a ﬁnal concentration of 70mM was added to neutralize TCA. The
reaction mixtures were then centrifuged again at 14,500 r.p.m. for 4min at room
temperature. Each sample was analysed in a ﬁnal volume of 100 ml containing
NADþ (6mM) and L-alanine dehydrogenase (1U) in 50mM NaHCO3, pH 10.
The kinetic of NADH formation was monitored at 340 nm during 20min to reach
completion. The curves were ﬁtted assuming ﬁrst-order kinetic42 and the
concentration of NADH corresponding to the total absorbance deviation at 340 nm
was calculated using an extinction coefﬁcient of 4,427M 1 cm 1 (determined
using L-alanine standard solutions).
For determination of the stoichiometry of the complexes by dose–response
experiments (Supplementary Fig. 2f–h), the reaction was performed with 20 mM of
the NFS1–ISD11 complex and increasing amounts of FXN and/or ISCU in the
presence of 0.5mM L-cysteine and 1mM DTT. Unless indicated, the other ADH
assays were performed with 20 mM of the NFS1–ISD11 complex and equimolar
amounts of ISCU (WT and mutants) and/or FXN. For determination of the kinetic
parameters, steady-state conditions were cautiously controlled. Accordingly, the
rate of alanine production reaches a steady-state (linear variation) afterB1min for
the NIUF complexes and 20min for the NIU complex (corresponding to the time
required for persulfuration of ISCU). Steady-state conditions were achieved in all
cases by (1) monitoring L-alanine production at four different time points to ensure
that the rates are actually linear and (2) selecting reaction times to ensure that no
more than 30% of L-cysteine or DTT were consumed. For L-cysteine, we considered
that three L-cysteine molecules are consumed for each L-alanine generated, as
cysteine is also consumed by the reduction process. The initial velocities were
determined from the linear regression using these four different time points.
Fe-S cluster assembly. Fe-S cluster assembly reactions were performed under
anaerobic conditions in a glove box. Before introduction into the glove box, all the
proteins were deoxygenated by ﬂushing the head space with argon and the buffer
by bubbling argon inside. The NSF1–ISD11 complex (50mM) was mixed with
equimolar amounts of ISCU with or without FXN in buffer C at 25 C. Then, 4 eq.
of Fe(NH4)2(SO4)2 were added and the solutions were incubated for 2min. The
reactions were initiated using 30 eq. of L-cysteine (1.5mM) with or without DTT
(1.5mM) and transferred to a septum-sealed cuvette. Ultraviolet–visible spectra
between 200 and 800 nm were recorded every minute on a Cary 100 (Varian)
spectrometer at 25 C.
Mass spectroscopy. The samples analysed by ESI-Q/TOF were prepared using
40 mM of the NFS1–ISD11 complex with or without equimolar amounts of
ISCU and/or FXN in buffer C at 25 C. The reactions were initiated with 10 eq.
of L-cysteine (400mM) and incubated for 3min at 25 C. The samples were
buffer exchanged in 50mM NH4OAc, pH 7 buffer using micro-biospin6. Proteins
were denatured for 5min in 50% acetonitrile and 1% formic acid. Mass spectro-
metry measurements were performed with an electrospray Q/TOF mass spectro-
meter (Q/TOF Premier, Waters) equipped with the Nanomate device (Advion).
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Spectra were recorded with an estimated mass accuracy of±1Da. The HD_A_384
chip (5mm i.d. nozzle chip, ﬂow rate range 100 500 nlmin 1) was calibrated
before use. For ESIMS measurements, the Q/TOF instrument was operated in
RF quadrupole mode with the TOF data being collected between m/z 300 and 2,990
for whole proteins. Collision energy was set to 6 eV and argon was used as the
collision gas. The Mass Lynx 4.1 software was used for acquisition and data pro-
cessing. Deconvolution of multiply charged ions was performed by applying the
MaxEnt1 algorithm. External calibration was performed with NaI clusters
(2mg ml 1, isopropanol/H2O 50/50) in the acquisition m/z mass range.
The samples analysed by Orbitrap-MS/MS were prepared in buffer C using
20mM of the NIU and NIUF complexes. The reactions were performed with L-
cysteine (400 mM) in a ﬁnal volume of 20 ml for 1min with the NIUF complex and
1 h with the NIU complex. Controls without L-cysteine were also analysed. The
reactions were stopped by adding 5 ml of buffer C containing 20mM of IAA and
were incubated for 15min at 30 C in the dark. The alkylation reaction continues
by adding 100 ml of buffer C containing 8M urea and 50mM IAA and incubate 1 h
at 30 C in the dark. Excess IAA was removed by TCA precipitation as described
for the alkylation assay. The protein pellets were resuspended in 20 ml of buffer C
containing 8M urea. The samples were diluted 8 in buffer C and incubated with
trypsin (2% of total protein mass) for 2 h at 37 C. Protein digests were analysed by
nano-liquid chromatography (nano-LC) ESI tandem mass spectrometry (MS/MS).
These were carried out on a U3000 Dionex nanoﬂow system connected to an LTQ
Orbitrap XL mass spectrometer (Thermo Fisher Scientiﬁc) equipped with a
nanoelectrospray source. The samples were run through a C18 nanocolumn (75mm
i.d. 50 cm, PepMap100 C18, 3 mm, 100Å; Dionex) after being injected onto a pre-
concentration column with a ﬂow rate of 20 ml min 1 of 0.1% TFA in water.
Peptides were then loaded on the analytical column equilibrated with 0.1% of
formic acid in water, and elution was carried out using a linear gradient from 2 to
60% of acetonitrile at a ﬂow rate of 250 nlmin 1 for 60min.
The mass spectrometer was operated in data-dependent mode to automatically
switch between Orbitrap MS and MS/MS in the linear trap. Survey full scan MS
spectra from 450 to 2,000Da were acquired in the Orbitrap set to a resolution
R¼ 60,000 at m/z 400, after accumulation of 500,000 charges on the linear ion trap.
The ions with the most intense signals (up to six, depending on signal intensity)
were sequentially isolated for fragmentation and analysis of fragments in the linear
ion trap using CID. Target ions already selected for MS/MS were dynamically
excluded for 30 s. MS/MS raw ﬁles were individually processed through a Proteome
Discoverer v1.3 (PD1.3) (Thermo Fisher Scientiﬁc, Les Ulis, France) workﬂow.
Identiﬁcation of proteins and the search for post-translational modiﬁcations were
done using the MASCOT search engine v2.4. For identiﬁcation, a tolerance of
5 p.p.m. was used for the mass of the precursors and 0.8Da for the mass of the
fragments.
The estimation of the percentages of persulfuration of the peptides was
performed by determination of the ratio of areas under the peaks of the
chromatograms. The areas were obtained by extracting and integrating the mass
intensity of each precursor identiﬁed. The percentages are reported as the ratio of
persulfurated versus total amount of the corresponding peptide
(persulfuratedþ unmodiﬁed) assuming that persulfuration does not modify the
ionization properties of the peptide.
HPLC analysis. The products of the cysteine desulfurase reaction were analysed
using HPLC. The reactions were performed in buffer C at 25 C using 2 mM NFS1–
ISD11 complex in a ﬁnal volume of 300 ml. The reaction was initiated with a 750-
fold excess of L-cysteine and was incubated for 1 h at 37 C. The small molecules
were separated from proteins using Amicon ultra (0.5ml) with a cutoff of 10 kDa.
The ﬁltrate, containing the small molecules, was derivatized using the ACCQ-ﬂuo
reagent kit. The samples (5ml) were injected at a ﬂow rate of 1mlmin 1, at 35 C,
on an AccQ-Tag column connected to an Alliance 2695 HPLC apparatus equipped
with a ﬂuo detector W2475. The separations were performed using a gradient as
described by the manufacturer.
Statistical analysis and software. All the graphics from the ﬁgures, unless
indicated, display one representative experiment. The kinetic parameters and s.e.
reported in the tables were determined from at least three independent experi-
ments. Prism 4.2 (GraphPad software) was used to ﬁt the curves and generate the
ﬁgures. ChemDraw Ultra 12.0 (CambridgeSoft) was used to draw the molecules.
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